Half of all cancers of the cervix (the lower part of the uterus [womb]) occur in women between the ages of 35 and 55 years. Every year more than 11 000 women in the United States are diagnosed with invasive cervical cancer, and nearly 4 000 will die from complications of this disease. Cervical cancer is preventable and curable if detected early. The November 21, 2007, issue of JAMA includes an article describing the use of careful follow-up and an imaging test called fluorine-18-labeled deoxyglucose-positron-emission tomographic scan (FDG-PET), a nuclear medicine scan that detects uptake of glucose by tumor cells, to assess tumor response to therapy, to predict survival outcomes, and to detect early recurrence of tumor cells.
Human papillomavirus infection—various strains of the human papillomavirus (HPV), a sexually transmitted viral infection, play a role in causing most cases of cervical cancer. A vaccine is now available that has the potential to prevent HPV infection in women.
Sexual history—multiple sexual partners, sexual activity in adolescent girls
Sexually transmitted diseases (STDs)—chlamydia, gonorrhea, syphilis, or HIV/AIDS increase the chance of acquiring HPV
Weak immune system, such as from HIV infection
Cigarette smoking—tobacco use increases the risk of precancerous changes
Grahic Jump Location
Regular screening for cervical cancer is recommended for all women. It should begin within 3 years of becoming sexually active or no later than age 21. In addition to a medical history and physical examination, screening may include
Papanicolaou (PAP) test—a test to detect abnormal cells in the cervix
HPV DNA test—a lab test that detects the most common types of HPV that are likely to lead to cervical cancer
If a woman has an abnormal PAP test result, additional tests are needed to confirm the diagnosis, determine the extent of the cancer, and direct treatment options.
Colposcopy—a special microscope that examines the cervix for abnormal cells
Biopsy—removal of small samples of tissue for examination
Visual examination of the bladder and colon by special scopes to examine inside the bladder (cytoscopy) and the lower part of the large intestine (proctoscopy) to determine the extent and possible spread of cancer to surrounding organs.
Imaging studies—chest x-ray, CT, MRI, and PET to determine the presence and potential spread of cancer cells
The choice of treatment and the long-term outcome of cancer of the cervix depend on the type and stage of cancer as well as physician recommendation and patient choice. The main treatment options for cervical cancer are surgery, radiation therapy, and chemotherapy.
American Cancer Society http://www.cancer.org
National Women's Health Information Center http://www.4woman.gov
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on human papillomavirus was published in the February 28, 2007, issue.
Sources: American Cancer Society, National Women's Health Information Center.
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.
TOPIC: CANCER
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.